| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/1997 | US5602176 Phenyl carbamate |
| 02/11/1997 | US5602175 Retroviral protease inhibitors |
| 02/11/1997 | US5602174 Treatment or prophylaxis of angina |
| 02/11/1997 | US5602173 Inhibit phosphodiesterase activity, tumor necrosis factor production |
| 02/11/1997 | US5602172 Methods of inhibiting Pneumocystis carinii pneumonia, Giardia lamblia, and Cryptosporidium and compounds useful therefor |
| 02/11/1997 | US5602170 Medicinal thiophene compounds |
| 02/11/1997 | US5602169 Useful in reducing neuronal damage during ischemic stroke |
| 02/11/1997 | US5602166 Administering an azaspirane derivatives |
| 02/11/1997 | US5602165 Transdermal absorptive drug formulation |
| 02/11/1997 | US5602164 Lipophilic derivative of amino acids |
| 02/11/1997 | US5602163 Selective agonists of 5-hydroxytryptamine receptors; useful in treatment of migraine headaches |
| 02/11/1997 | US5602162 Imidazole, triazole and tetrazole derivatives |
| 02/11/1997 | US5602161 Elastase inhibitors; preventing and treating emphysema, endotoxin-induced lung disorders |
| 02/11/1997 | US5602157 Compounds useful for treating allergic and inflammatory diseases |
| 02/11/1997 | US5602156 Administering in treatment for nerve disorders, arthritis, alzheimer's disease, wound healing, corneal ulcers and fertility problems |
| 02/11/1997 | US5602155 Platelet aggregation inhibitors |
| 02/11/1997 | US5602154 Administering an enzyme inhibitor treating degenerative diseases |
| 02/11/1997 | US5602153 Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a giaucoma disorder |
| 02/11/1997 | US5602152 Benzoxepines |
| 02/11/1997 | US5602150 Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia |
| 02/11/1997 | US5602149 1-OXO-2-(phenylsulphonylamino)pentypiperidine derivatives, their preparation and their therapeutic application |
| 02/11/1997 | US5602148 Polyethylene glycol as a solubilizer |
| 02/11/1997 | US5602147 Piperidinyl thiacyclic derivatives |
| 02/11/1997 | US5602146 Antiviral agent |
| 02/11/1997 | US5602145 Anticoagulants |
| 02/11/1997 | US5602144 Thienopyridones |
| 02/11/1997 | US5602143 Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors |
| 02/11/1997 | US5602142 Promoter for improving radiosensitization and chemosensitization |
| 02/11/1997 | US5602141 Camptothecin derivatives and process for their preparation |
| 02/11/1997 | US5602139 Method for ameliorating the adverse effects of aging |
| 02/11/1997 | US5602138 Neurokinin a antagonists; treating asthma |
| 02/11/1997 | US5602137 Treating cardiovascular or circulatory disorders |
| 02/11/1997 | US5602136 Cardiovascular and nervous system disorders |
| 02/11/1997 | US5602135 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
| 02/11/1997 | US5602134 Useful for treating animals suffering from congestive heart failure |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602131 EburnanE analogues |
| 02/11/1997 | US5602130 Ornithine decarboxylase enzyme inhibitor treating skin disorder, inhibiting cell hyperproliferation |
| 02/11/1997 | US5602129 N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| 02/11/1997 | US5602127 Administering to treat hypertension |
| 02/11/1997 | US5602123 Therapeutic agent for myocardial ischemic damages or reperfusion |
| 02/11/1997 | US5602118 A 2-((2-substituted alkyl)fur-3-yl)-thio-),3-carboxy-2-carbopenem derivatives; effective against beta-lactam antibiotic-resistant bacteria |
| 02/11/1997 | US5602117 Cephalosporin compounds |
| 02/11/1997 | US5602116 Administering vitamin d analog |
| 02/11/1997 | US5602115 Bisphosphonic acid derivatives as anti-arthritic agents |
| 02/11/1997 | US5602110 Using mixture of a phosphodiesterase inhibiot and adenylate cyclase |
| 02/11/1997 | US5602109 Feeding human infant dietary formula that alleviates diarrhea; contains ribonucleotides |
| 02/11/1997 | US5602108 Antitumor agents |
| 02/11/1997 | US5602104 Skin disorders, conjunctive tissue disorders, antitumor agents |
| 02/11/1997 | US5602103 Cerebral function-ameliorating agent |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601999 Antitumor polysaccharide-glycan complexes |
| 02/11/1997 | US5601981 Methods for determining and agents for modulating cellular redox potential and genotoxic states |
| 02/11/1997 | US5601848 Administering bismuth compound |
| 02/11/1997 | US5601845 Cores containing diltiazem(or salt) and microcrystalline cellulose coated with ethyl cellulose, for controlled release oral drug delivery |
| 02/11/1997 | US5601844 Sustained release medicinal preparation |
| 02/11/1997 | US5601843 Core of non-steroidal anti-inflammatory agent surrounded by mantle of a prostaglandin; stability |
| 02/11/1997 | US5601842 Analgesics; contains a non-moisture sensitive matrixing agent |
| 02/11/1997 | US5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| 02/11/1997 | US5601838 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia |
| 02/11/1997 | US5601837 Oral pharmaceutical composition comprising small particle size psyllium husk, cholestyramine resin |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |
| 02/11/1997 | US5601806 Methods for scavenging active oxygen compounds and preventing damage from ultra violet B rays using taurine analogues |
| 02/11/1997 | US5601804 Antiplaque agent |
| 02/11/1997 | US5601799 Glycoprotein has affinity to macrophages, useage as drug delivery |
| 02/11/1997 | CA2034546C 1, 3-dicarbonyl compounds and their use |
| 02/11/1997 | CA2008628C Substance uct-1003 and process for producing the same |
| 02/11/1997 | CA1338908C Aminoalkylthio derivatives of triazolopyridine or triazoloquinoline, the processes for their preparation, and drugs, useful especially as analgesics in which they are present |
| 02/11/1997 | CA1338906C 11 beta-substituted progesterone analogs |
| 02/06/1997 | WO1997004127A1 Diagnostic test for schizophrenia by analysing allelic variations in the cytosolic phospholipase a2 gene |
| 02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004012A1 Polysaccharide gel composition |
| 02/06/1997 | WO1997004009A1 Colostrum derived growth factor |
| 02/06/1997 | WO1997004005A2 Cyclosporin derivatives with anti-hiv effect |
| 02/06/1997 | WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 02/06/1997 | WO1997004002A1 EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5α-ANDROST-1-ENE-17β-CARBOXAMIDE |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003995A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | WO1997003988A1 Antiparasitic marcfortines and paraherquamides |
| 02/06/1997 | WO1997003987A1 Novel galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 02/06/1997 | WO1997003985A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 02/06/1997 | WO1997003984A1 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/06/1997 | WO1997003983A1 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl]-4(s)oxazolidin-2-one monobenzoate and sulphate salt |
| 02/06/1997 | WO1997003982A1 Piperazine derivatives and their use as 5-ht1a antagonists |
| 02/06/1997 | WO1997003979A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists |
| 02/06/1997 | WO1997003978A1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 02/06/1997 | WO1997003973A1 4,5-diaryl oxazole derivatives |
| 02/06/1997 | WO1997003960A1 NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) |
| 02/06/1997 | WO1997003959A1 Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 02/06/1997 | WO1997003958A1 Form iii crystalline (r-(r*,r*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 02/06/1997 | WO1997003957A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 02/06/1997 | WO1997003953A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |